BREAST AND OVARIAN CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 51 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Hereditary Breast and Ovarian Cancer Panel allows the identification of pathogenic variants in genes involved in major cancer predisposition syndromes, including BRCA1/BRCA2, Lynch syndrome, Li-Fraumeni syndrome, and Cowden syndrome, among others. These alterations significantly increase the risk of breast, ovarian, fallopian tube, prostate, and pancreatic cancer. Clinical exome sequencing and CNV detection provide essential information for clinical management, genetic counseling, and therapeutic decision-making, including the use of targeted therapies (such as PARP inhibitors). Genes analyzed: BRCA1, BRCA2, CHEK2, ATM, PALB2, TP53, PTEN, RAD51C, RAD51D, and others. You can obtain the complete list of analyzed genes by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€